| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/09/2002 | EP0825863B1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 10/09/2002 | EP0783310B1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 10/09/2002 | EP0772590B1 Thrombin inhibitors |
| 10/09/2002 | EP0756484B1 Wet granulation formulation for bisphosphonic acids |
| 10/09/2002 | EP0754189B1 Receptor modulating agents and methods relating thereto |
| 10/09/2002 | EP0683774B1 Hypolipidaemic compounds |
| 10/09/2002 | EP0679082B1 C10 taxane derivatives and pharmaceutical compositions |
| 10/09/2002 | CN1373805A Antigenic meningococcal peptides |
| 10/09/2002 | CN1373769A Betulinic acid derivs, having antiangiogenic activity, processes for producing such derivs. and their use for treating tumor associated angiogenesis |
| 10/09/2002 | CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 10/09/2002 | CN1373767A Ketolide antibacterials |
| 10/09/2002 | CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs. |
| 10/09/2002 | CN1373763A Pteridinones and kinase inhibitors |
| 10/09/2002 | CN1373762A Phenanthroline-7-one derivs. and their therapeutic applications |
| 10/09/2002 | CN1373761A Phenanthroline-7-one derivs. and their therapeutic uses |
| 10/09/2002 | CN1373760A Quinuclidine derivs. as muscarinic M3 receptors ligand and their use |
| 10/09/2002 | CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same |
| 10/09/2002 | CN1373755A Azacycloalkanone serine protease inhibitors |
| 10/09/2002 | CN1373754A Antibacterial agents |
| 10/09/2002 | CN1373753A Mutual salt of amlodipine and atorvastatin |
| 10/09/2002 | CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds |
| 10/09/2002 | CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 10/09/2002 | CN1373746A Method for reducing 2-dimethylamino-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 10/09/2002 | CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs. |
| 10/09/2002 | CN1373675A Composition for IVF |
| 10/09/2002 | CN1373667A Formulations for parenteral use of estramustine phosphate and amino acids |
| 10/09/2002 | CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 10/09/2002 | CN1373665A Pharmaceutical solutions for levosimendan |
| 10/09/2002 | CN1373664A Therapeutic method |
| 10/09/2002 | CN1373663A Use of 2-imidazolyl substd, carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions |
| 10/09/2002 | CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents |
| 10/09/2002 | CN1373661A Ophthalmic fluid |
| 10/09/2002 | CN1373660A Method for treating chronic pain using MEK inhibitors |
| 10/09/2002 | CN1373659A Solid lipid formulations |
| 10/09/2002 | CN1373657A Method for controlled production of ultrafine microparticles and nanoparticles |
| 10/09/2002 | CN1373656A Dispersion formulations contg. lipase inhibitors |
| 10/09/2002 | CN1373655A Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 10/09/2002 | CN1373127A Crystal choline ascorbate |
| 10/09/2002 | CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide |
| 10/09/2002 | CN1373115A Synthesizing process for phenylhydroxy acetic acid and its salts, and application thereof in treating malaria |
| 10/09/2002 | CN1372945A Magnetotherapeutic medicinal pad and its preparing process |
| 10/09/2002 | CN1372938A Composite vitamine and trace-element nutrient for gravida and puerpera |
| 10/09/2002 | CN1372936A Antineoplastic |
| 10/09/2002 | CN1372935A Slowly released clamycin capsule |
| 10/09/2002 | CN1372934A Application of N-acetyl-D-aminoglucose in preparing medicines to treat cardiac and cerebral ischemia and anoxia |
| 10/09/2002 | CN1372933A Application of N-acetyl-D-aminoglucose in preparing medicine to prevent and treat motion sickness |
| 10/09/2002 | CN1372932A Application of N-acetyl-D-aminoglucose in preparing medicine to help treatment of perianal diseases |
| 10/09/2002 | CN1372931A Application of N-acetyl-D-aminoglucose in preparing medicines to treat cervical erosion |
| 10/09/2002 | CN1372930A Application of N-acetyl-D-aminoglucose in preparing medicines to prevent and treat sexual disfunction |
| 10/09/2002 | CN1372929A Application of N-acetyl-D-aminoglucose in preparing medicines to suppress by-effect of radiotherapy and chemicotherapy |
| 10/09/2002 | CN1372928A Application of ketanserin in improving myocardial infarction prognosis |
| 10/09/2002 | CN1372927A Application of phenazinone derivative in preparing antineoplastic and tumor transfer-resistant medicines |
| 10/09/2002 | CN1372926A Medicinal ointment containing zinc conjugated linoleate and sodium humate |
| 10/09/2002 | CN1372923A Release controlled Tuoteluoding Tartrate and its preparing process |
| 10/09/2002 | CN1372922A Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
| 10/09/2002 | CN1092204C Semisynthesizing method for 20(S)-ginsenoside Rg3, and use thereof in medicine |
| 10/09/2002 | CN1092202C Substd. aminoalkane phosphonic acids |
| 10/09/2002 | CN1092198C Z-mercapto-ethylamine cyclized hypocrellin and preparation process and use thereof |
| 10/09/2002 | CN1092194C Diaminopyrimidines, pharmaceutical compositions contg. them and their use as antibacterial |
| 10/09/2002 | CN1092193C Prolylendopeptidase inhibitors |
| 10/09/2002 | CN1092192C Pyrrolyl tetrahydroquinoxalin diones, their production and use in treatment of diseases |
| 10/09/2002 | CN1092185C Dihydrodibenzo isoquinolines diketone, its pharmaceutical composition and use, and method for preparing same |
| 10/09/2002 | CN1092067C Medicine for treating multiple skin diseases and its preparing process |
| 10/09/2002 | CN1092066C Analgesic plaster for osteoarthritis |
| 10/09/2002 | CN1092060C Ointment for exterior use for treating burns and scalds |
| 10/09/2002 | CN1092050C Mixed povidone iodine disinfectant and preparing method thereof |
| 10/09/2002 | CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof |
| 10/09/2002 | CN1092048C Compound piperaquine tablet |
| 10/09/2002 | CN1092047C Chemical compound for treating cancer and preparing process thereof |
| 10/09/2002 | CN1092046C Local medicine composition for healing wound |
| 10/09/2002 | CN1092045C Vesicular complexes and methods of making and using same |
| 10/09/2002 | CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same |
| 10/09/2002 | CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same |
| 10/08/2002 | WO2001080874A1 Bone-strengthening agents, food compositions for strengthening bone and feed compositions for strengthening bone |
| 10/08/2002 | US6462222 Aminoindan derivatives |
| 10/08/2002 | US6462211 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
| 10/08/2002 | US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia, |
| 10/08/2002 | US6462196 Preparation of a camptothecin derivative by intramolecular cyclization |
| 10/08/2002 | US6462182 Chemotherapy, microbial infections; enhanced solubility; catalysis, hydrolysis |
| 10/08/2002 | US6462169 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
| 10/08/2002 | US6462094 Phenylephrine tannate and guaifenesin; oral administrationfor symptomatic relief of cough associated with respiratory tract conditions such as common cold, bronchial asthma, acute and chronic bronchitis |
| 10/08/2002 | US6462091 A tertiary amine substituted with a monochlorinated diphenyl-ether, a phenylperfluoroethyl ether and a hydroxylated fluorinated alkane; synergistic with mevastatin, lovastatin, simvastatin, pravastatin, fluvastatin or atorvastatin |
| 10/08/2002 | US6462090 Formulations for detecting asthma |
| 10/08/2002 | US6462089 Modafinil; restoring a normal sleep pattern; myotonic dystrophy |
| 10/08/2002 | US6462087 Anti-tumor composition |
| 10/08/2002 | US6462086 Non-malignant disease treatment with Ras antagonists |
| 10/08/2002 | US6462084 Gamma vinyl gamma amino butyric acid; prolonged effect; irreversible enzyme inhibitor that raises endogenous levels without addiction |
| 10/08/2002 | US6462083 Suppository base |
| 10/08/2002 | US6462082 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 10/08/2002 | US6462081 5-thia-ω-substituted phenyl-prostaglandin E derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 10/08/2002 | US6462080 Prostaglandin E receptor agonists for treatment of dry eye |
| 10/08/2002 | US6462079 Pharmaceutical composition and method of using the same |
| 10/08/2002 | US6462078 Antiinflammatory agents; library of plant extracts |
| 10/08/2002 | US6462077 Thromboxane ligands without blood clotting side effects |
| 10/08/2002 | US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 10/08/2002 | US6462074 Substituted α, β-anellated butyrolactones |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6462072 Such as 4,4-diphenylcyclohexl-1-(3,3-dimethyl-2-oxopentan-oyl)-pyrrolidine-2 -carboxylate; rotamase inhibitors; neuronal repair and regrowth; parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis |
| 10/08/2002 | US6462071 Agents for intravitreal administration to treat or prevent disorders of the eye |
| 10/08/2002 | US6462070 Photosensitizer conjugates for pathogen targeting |